Literature DB >> 17521535

The metabolic syndrome in a global perspective. The public health impact--secondary publication.

Knut Borch-Johnsen1.   

Abstract

The term "metabolic syndrome" refers to the clustering of a number of cardiovascular risk factors (obesity, hypertension, dyslipidemia and hyperglycaemia) believed to be related to insulin resistance. The prevalence of each of these diseases as well as the metabolic syndrome is increasing world wide. Obesity, hypertension, dyslipidemia and diabetes are no longer diseases of the wealthy. By 2025, three out of four people with diabetes will be living in third world countries, and similar trends are likely for the other components of the syndrome. Preventive action is urgently needed, and studies in China and India have proven to be effective.

Entities:  

Mesh:

Year:  2007        PMID: 17521535

Source DB:  PubMed          Journal:  Dan Med Bull        ISSN: 0907-8916


  23 in total

1.  "Obesity-Associated" Breast Cancer in Lean Women: Metabolism and Inflammation as Critical Modifiers of Risk.

Authors:  Gerald V Denis; Julie R Palmer
Journal:  Cancer Prev Res (Phila)       Date:  2017-04-13

Review 2.  BET proteins in abnormal metabolism, inflammation, and the breast cancer microenvironment.

Authors:  Guillaume P Andrieu; Jordan S Shafran; Jude T Deeney; Kishan R Bharadwaj; Annapoorni Rangarajan; Gerald V Denis
Journal:  J Leukoc Biol       Date:  2018-03-01       Impact factor: 4.962

3.  Association between insulin resistance and c-reactive protein among Peruvian adults.

Authors:  Bizu Gelaye; Luis Revilla; Tania Lopez; Luis Suarez; Sixto E Sanchez; Karin Hevner; Annette L Fitzpatrick; Michelle A Williams
Journal:  Diabetol Metab Syndr       Date:  2010-05-18       Impact factor: 3.320

4.  Association of breastfeeding and risk of metabolic syndrome and its components in postmenopausal parous women: Korea national health and nutrition examination survey (2010 ~ 2016).

Authors:  Jusuk Lee; Taehong Kim
Journal:  Arch Public Health       Date:  2021-05-19

5.  Ethnic differences in the prevalence of metabolic syndrome: results from a multi-ethnic population-based survey in Malaysia.

Authors:  Sanjay Rampal; Sanjiv Mahadeva; Eliseo Guallar; Awang Bulgiba; Rosmawati Mohamed; Ramlee Rahmat; Mohamad Taha Arif; Lekhraj Rampal
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

6.  Prevalence of metabolic syndrome in urban India.

Authors:  Apurva Sawant; Ranjit Mankeshwar; Swarup Shah; Rani Raghavan; Gargi Dhongde; Himanshu Raje; Shoba D'souza; Aarti Subramanium; Pradnya Dhairyawan; Seema Todur; Tester F Ashavaid
Journal:  Cholesterol       Date:  2011-05-19

7.  Prevalence of metabolic syndrome in Iranian professional drivers: results from a population based study of 12,138 men.

Authors:  Iraj Mohebbi; Soheil Saadat; Mohammadreza Aghassi; Mahsa Shekari; Maghsuod Matinkhah; Shadi Sehat
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

8.  'Diabetology & Metabolic Syndrome: providing an open access future for diabetes research'.

Authors:  Daniel Giannella-Neto; Marília de Brito Gomes
Journal:  Diabetol Metab Syndr       Date:  2009-08-26       Impact factor: 3.320

9.  Serum vitamin D status and metabolic syndrome: a systematic review and dose-response meta-analysis.

Authors:  Kyueun Lee; Jihye Kim
Journal:  Nutr Res Pract       Date:  2020-12-29       Impact factor: 1.926

10.  Estrogen signalling and the metabolic syndrome: targeting the hepatic estrogen receptor alpha action.

Authors:  Marko Matic; Galyna Bryzgalova; Hui Gao; Per Antonson; Patricia Humire; Yoko Omoto; Neil Portwood; Camilla Pramfalk; Suad Efendic; Per-Olof Berggren; Jan-Åke Gustafsson; Karin Dahlman-Wright
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.